FDA review confirms safety, efficacy of single-shot Johnson & Johnson coronavirus vaccine, especially against severe cases
WASHINGTON - A third coronavirus vaccine could soon be available in the United States, a one-shot regimen made by pharmaceutical giant Johnson & Johnson that proved safe and effective in a clinical trial and completely protective against hospitalizations and deaths, according to a Food and Drug Administration review released Wednesday.